home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

QRM Applications for Pharmaceutical Manufacturing Facilities

 
  October 30, 2014  
     
 
CfPA-The Center for Professional Advancement, Amsterdam, The Netherlands
11-11 March 2015


Who Should Attend
This introductory/intermediate course is designed for individuals who need a basic, but thorough understanding of key principles of Quality Risk Management (QRM) and how to apply them over the product/system life cycle and within Quality Systems.

The course will benefit individuals in:
  • Engineering 
  • Technical Services/Validation
  • Production 
  • Quality Control/Assurance
  • R&D 
  • Regulatory Affairs
  • University and allied health care professionals

Description
Quality Risk Management (QRM) is an expected element of a company's site quality system that is subject to review as a part of a regulatory inspection, and is typically governed by corporate or site policy and procedures. Many times, QRM can be perceived as a documentation exercise where the results get filed in the site document management system, yet have no real impact on driving improvements or reducing the company's overall risk profile. A fully functioning QRM program can lead to shared process understanding between cross-functional team members, identification of critical aspects for processes or equipment that can streamline qualification and validation activities, recognition of critical gaps in process understanding, and a clearly defined and documented risk control strategy.

This one-day, intensive course will introduce the key principles of QRM across the product/system life cycle and within Quality Systems. Topics discussed include an introduction and overview of Quality Risk Management, philosophy and application of a holistic QRM process; an overview and appropriate use of risk assessment tools; the application of risk management methodologies throughout specification, design, verification, and manufacturing. Course workshops will include use of risk assessment tools and developing the structure of a site QRM Program.

Maximize Your Learning!
Attend this course and its Companion Course:
IQ, OQ, PQ 
9 March 2015 • Amsterdam • Course ID #1808

 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers: Steven J. Wisniewski; Principal Consultant, CAI Consulting

Steven J. Wisniewski is Principal Compliance Consultant for CAI Consulting, provider of consulting services for biotech and pharmaceutical manufacturers world-wide. CAI Consulting focuses on the manufacturing process, with services including commissioning, validation, technology transfer, owner project management, maintenance programs, SOPs, training and cGMP compliance.

Mr. Wisniewski offers more than 30 years experience in the pharmaceutical, biotech, and device industries. Prior to joining CAI he was Senior Associate and Director of Compliance for IPS. Mr. Wisniewski has served in senior management roles at Sterling Winthrop and Bausch & Lomb. He has completed a wide variety of pharmaceutical manufacturing, filling and critical support operations to major R&D laboratories, facilities and upgrades. He holds a BSME from Rensselaer Polytechnic Institute, is a Member of PDA, and an active Member of ISPE. He served on the ISPE board of directors beginning in 1982, and was chairman of the board in 1991. He served four terms as Chairman of the ISPE Community of Practice for Commissioning and Qualification, was a lead on the Task Team that drafted the ISPE Guide in support of Risk-based Qualification and served on Task Team that completed the ISPE Good Practice Guide to address transitional Science and Risk-based (ICH Q9) approaches for C&Q. He was on the Team that developed the ASTM E2500 Standard and has also served as course leader and/or presenter at multiple ISPE conferences and co-authored several C&Q related articles.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.